Guidance on point of care testing for COVID-19
This document provides guidance from the National Pathology Accreditation Advisory Council (NPAAC) on the use of point of care testing to support increased testing demand for SARS-CoV-2 during the coronavirus disease 2019 (COVID-19) outbreak.
Notice
From 1 July 2021, the Australian Commission on Safety and Quality in Health Care (the Commission) is responsible for coordinating the Australian Pathology Accreditation (APA) Scheme and managing the development of the pathology accreditation standards.
For enquiries about the APA Scheme or this document, email pathology@safetyandquality.gov.au.
Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by completing this form.